Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
0.3237
+0.0067 (+2.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Applied Dna Scns
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
InvestorNewsBreaks — Applied DNA Sciences Inc. (NASDAQ: APDN) Closes on $4.2M Registered Direct Offering
March 11, 2022
Via
Investor Brand Network
Applied DNA Raises $4.2M Via Registered Direct Offering
February 25, 2022
Applied DNA Sciences, Inc. (NASDAQ:APDN) a polymerase chai...
Via
Benzinga
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
February 24, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Sciences To Raise $4.2M Via Registered Direct Offering
February 22, 2022
Applied DNA Sciences, Inc. (NASDAQ:APDN), a polymera...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 22, 2022
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million....
Via
Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
February 22, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
February 17, 2022
Gainers Creative Medical Tech (NASDAQ:CELZ
Via
Benzinga
Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy
February 17, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Looking Into Applied DNA Sciences's Return On Capital Employed
February 14, 2022
Applied DNA Sciences (NASDAQ:APDN) brought in sales totaling $4.17 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 4.73%, resulting in a loss of $4.72...
Via
Benzinga
78 Biggest Movers From Friday
February 14, 2022
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 11, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI...
Via
Benzinga
41 Stocks Moving In Friday's Mid-Day Session
February 11, 2022
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations...
Via
Benzinga
Recap: Applied DNA Sciences Q1 Earnings
February 10, 2022
Applied DNA Sciences (NASDAQ:APDN) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
52 Weeks High And Low Article
February 11, 2022
On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company...
Via
Benzinga
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
February 10, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
February 03, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
January 28, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit
January 21, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Announces Continued Momentum in COVID-19 Testing Demand
January 18, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test
January 04, 2022
From
Applied DNA Sciences, Inc.
Via
Business Wire
Applied DNA and Stratum Reservoir (Isotech) Sign Memorandum of Understanding to Leverage Isotopic Analysis for Enhanced DNA-Based Cotton Authenticity and Provenance
December 15, 2021
From
Applied DNA Sciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 15, 2021
Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 10, 2021
Gainers Quoin Pharmaceuticals (NASDAQ:
Via
Benzinga
Applied DNA Sciences Earnings Perspective: Return On Capital Employed
December 10, 2021
Benzinga Pro data, Applied DNA Sciences (NASDAQ:APDN) reported Q4 sales of $3.00 million. Earnings fell to a loss of $4.51 million, resulting in a 30.78% decrease from last...
Via
Benzinga
18 Stocks Moving in Friday's Pre-Market Session
December 10, 2021
Gainers Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ONA-XR in early breast cancer. The company said ONA-...
Via
Benzinga
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares
December 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Angion Biomedica's ANG-3777 Does Not Meet Primary Endpoint In Mid-Stage...
Via
Benzinga
Applied DNA Sciences' Q4 Revenues Skyrockets Buoyed By Momentum In COVID-19 Diagnostic Testing
December 10, 2021
Applied DNA Sciences Inc (NASDAQ: APDN) reported a more than ninefold Y/Y increase in Q4 FY21 revenues, driven by the rise in clinical laboratory service revenues related to...
Via
Benzinga
Exposures
COVID-19
Applied DNA Sciences: Q4 Earnings Insights
December 09, 2021
Applied DNA Sciences (NASDAQ:APDN) reported its Q4 earnings results on Thursday, December 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 09, 2021
Gainers Applied DNA Sciences (NASDAQ:APDN...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.